Researchers in Australia have used 2D gel electrophoresis and mass spectrometry to identify proteins and pathways that may play a role in schizophrenia.
In a study published in the October issue of Proteomics Clinical Applications, the research team, consisting of scientists from the Schizophrenia Research Institute in Sydney and the University of Sydney, identified 34 proteins expressed in a certain portion of the brain of schizophrenia patients.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.